11 Nov 2020
Increasing investments particularly in the research and development activities as well as strong government support is anticipated to propel the global coronavirus vaccine market. In addition, the present coronavirus outbreak has led to an increasing demand for the vaccines all over the world.
Increasing Demand For The Vaccines Along With High Geriatric Population Is Boosting The Global Coronavirus Vaccine Market Growth
North America To Account Highest Revenue Share In The Global Coronavirus Vaccine Market
North America is the region that is expected to account for the biggest share of the global coronavirus vaccine market as far as revenue is considered. This trend is further expected to be followed by Europe accounting for the second-highest global coronavirus vaccine market share in terms of revenue. Such good growth of the global coronavirus vaccine market is due to the various coronavirus outbreaks recently along with the major players present in these regions. Not only this,high investments made for the research and development activities as well as strong governmentsupport is further propelling the global coronavirus vaccine market in these regions. Asia Pacific is also expected to witness considerable growth due to the present coronavirus outbreak. Additionally, increasing demand as well as the high demand for new vaccines and therapeutics so as to use them as preventive measures is also expected to boost the global coronavirus vaccine market regionally.
Essilor International S.A.; Alcon Vision LLC; Abbott Medical Optics, Inc.; CooperVision, Inc.; Bausch & Lomb, Incorporated; ZEISS International; Contamac; Hoya Corporation; SynergEyes, Inc.; X-Cel Specialty Contacts; Johnson & Johnson Vision Care, Inc.; Medennium; Seed Co., Ltd.; STAAR Surgical Company and among others.
Essilor Group is leading ophthalmic optics company established in 1849 and headquarter in Charenton le Pont Cedex. Specialties in Ophtalmic products, services and instruments for eyecare professionals, equipments for laboratories, visual solutions, eyewear, and sunglasses.
Essilor reported consolidated revenue of nearly €7.9 billion in 2019 and employs close to 74,000 people worldwide.
Alcon is the global leader in eye care established in 1945 and headquarter in Geneva, Switzerland. Specialties in Ophthalmology Pharmaceuticals and Medical Devices, Eye care, and Eye health.
AbbVie is an American publicly traded biopharmaceutical company established in 2013 and headquarter in North Chicago, Illinois. Specialties in Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, and Womens Health.
Novavax, Inc. is an American vaccine development company established in 1987 and headquarter in Gaithersburg, Maryland. Specialties in discovery, development, and commercialization of innovative vaccines.
Novavax Focused on creating the next generation of revolutionary vaccines.
BioCryst Pharmaceuticals, Inc.established in 1986 and headquarter in Durham, NC.
Specialties in Drug Discovery, Clinical Development, Rare Diseases, Regulatory Affairs, and Product Commercialization.
BioCryst has more than 100 employees and is experiencing continuous growth.
Inovio Pharmaceuticals is an American biotechnology company headquarter in Plymouth Meeting, PA. Specialties in DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company established in 1988 and headquarter in Tarrytown, New York. Specialties in neurotrophic factors and their regenerative capabilities.
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer established in 1982 and headquarter in Monrovia, CA.
Along with these leading players, there are number of other small and mid-sized players who are coming with huge investment and innovative product launch in the Coronavirus Vaccine industry.
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.